2023
Prevalence of injecting drug use and HIV, hepatitis B, and hepatitis C in people who inject drugs in the Eastern Mediterranean region: a systematic review and meta-analysis
Aghaei A, Gholami J, Sangchooli A, Rostam-Abadi Y, Olamazadeh S, Ardeshir M, Baheshmat S, Shadloo B, Taj M, Saeed K, Rahimi-Movaghar A. Prevalence of injecting drug use and HIV, hepatitis B, and hepatitis C in people who inject drugs in the Eastern Mediterranean region: a systematic review and meta-analysis. The Lancet Global Health 2023, 11: e1225-e1237. PMID: 37474230, DOI: 10.1016/s2214-109x(23)00267-x.Peer-Reviewed Original ResearchConceptsPrevalence of injection drug useInjection drug usePrevalence of HIVHepatitis B virusHepatitis C virusB virusC virusMeta-analysisSystematic reviewHepatitis C virus infection ratesEastern Mediterranean RegionCharacteristics of peopleDrug useHIV infection ratesOpioid agonist treatmentInfection rateProgramme servicesPopulation size of peopleHepatitis CAgonist treatmentHarm reduction servicesHepatitis BWHO Eastern Mediterranean RegionWeb of ScienceProvision of services
2022
Mortality and negative outcomes of opioid use and opioid use disorder: a 6‐year follow‐up study
Gholami J, Baheshmat S, Rostam‐Abadi Y, Hamzehzadeh M, Mojtabai R, Rahimi‐Movaghar A, Amin‐Esmaeili M. Mortality and negative outcomes of opioid use and opioid use disorder: a 6‐year follow‐up study. Addiction 2022, 117: 2059-2066. PMID: 35037359, DOI: 10.1111/add.15805.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAdultAnalgesics, OpioidFollow-Up StudiesHumansIranMiddle AgedOpioid-Related DisordersSuicide, AttemptedYoung AdultConceptsComposite International Diagnostic InterviewOutcomes of opioid use disorderOpioid use disorderOpioid useDeath registration systemFollow-up studyWeighted incidence rateMiddle-income countriesAdverse outcomesNegative consequences of opioid useUse disorderFollow-up interviewsCohort of individualsOutcomes of opioid useConsequences of opioid useHealth outcomesFollow-upVital statusAssociated with increased mortalityTelephone callsDiagnostic InterviewRegistration systemPopulation-wereDeath rateHousehold survey
2021
Public health risks associated with methadone in Iran: A systematic review and meta-analysis
Rostam-Abadi Y, Gholami J, Noroozi A, Ansari M, Baheshmat S, Hamzehzadeh M, Ghadirzadeh M, Vahdani B, Ekhtiari H, Mojtabai R, Rahimi-Movaghar A. Public health risks associated with methadone in Iran: A systematic review and meta-analysis. International Journal Of Drug Policy 2021, 100: 103529. PMID: 34826790, DOI: 10.1016/j.drugpo.2021.103529.Peer-Reviewed Original ResearchMeSH KeywordsAdultAnalgesics, OpioidChildFemaleHumansIranMaleMethadoneOpiate Substitution TreatmentOpioid-Related DisordersPublic HealthConceptsMethadone maintenance treatmentNon-prescribed useMethadone useSystematic reviewGeneral populationPositive health outcomesUse disorderFemale general populationSystematic review of studiesSixty-five studiesRandom-effects modelLegal Medicine OrganizationMethadone maintenance treatment programsPublic health concernHealth outcomesSubstance-related deathsReview of studiesPooled proportionCases of acute poisoningMaintenance treatmentMedicine organizationsDrug treatment centersIranian databasesAdverse outcomesPrescription opioidsBuprenorphine abuse and health risks in Iran: A systematic review
Ansari M, Rostam-Abadi Y, Baheshmat S, Hamzehzadeh M, Gholami J, Mojtabai R, Rahimi-Movaghar A. Buprenorphine abuse and health risks in Iran: A systematic review. Drug And Alcohol Dependence 2021, 226: 108871. PMID: 34214882, DOI: 10.1016/j.drugalcdep.2021.108871.Peer-Reviewed Original ResearchConceptsBuprenorphine maintenance treatmentSystematic reviewPrevalence of non-prescribed useNon-prescribed useInternational electronic databasesBuprenorphine poisoningCompared to other opioidsBuprenorphine useElectronic databasesPoisoning casesIdentified recordsDrug poisoning casesIranian databasesGeneral populationEligibility criteriaTreatment-seekingNational studyRegular useNon-prescribed buprenorphine useMaintenance treatmentBuprenorphineHealth risksBuprenorphine abusePrevalenceRelevant dataComparison of self-reported substance use with biological testing among treatment-seeking patients with opioid use disorder
Shadloo B, Baheshmat S, Rostam-Abadi Y, Shakeri A, Gholami J, Rahimi-Movaghar A. Comparison of self-reported substance use with biological testing among treatment-seeking patients with opioid use disorder. Journal Of Substance Use And Addiction Treatment 2021, 134: 108555. PMID: 34210569, DOI: 10.1016/j.jsat.2021.108555.Peer-Reviewed Original ResearchMeSH KeywordsAnalgesics, OpioidCross-Sectional StudiesHumansIranOpioid-Related DisordersSelf ReportUrinalysisConceptsOpioid use disorderSelf-reported opioid useOpioid usePositive percent agreementUrine testsTreatment-seeking patientsCohen's kappa statisticPercent agreementUse disorderKappa statisticNegative predictive valueLonger treatment durationMonitoring treatment adherenceRandom urine testingResults of urinalysisValidity of self-reported drug useCross-sectional studySelf-reported substance useSelf-reported drug useTreatment durationOpioidPredictive valuePatientsTreatment adherenceDrug use
2020
Tramadol use and public health consequences in Iran: a systematic review and meta‐analysis
Rostam‐Abadi Y, Gholami J, Amin‐Esmaeili M, Safarcherati A, Mojtabai R, Ghadirzadeh M, Rahimi H, Rahimi‐Movaghar A. Tramadol use and public health consequences in Iran: a systematic review and meta‐analysis. Addiction 2020, 115: 2213-2242. PMID: 32196801, DOI: 10.1111/add.15059.Peer-Reviewed Original ResearchConceptsPooled estimatesSystematic reviewConsistent with Preferred Reporting ItemsPrevalence of non-prescribed useIranian general populationPreferred Reporting ItemsPublic health challengeSystematically review studiesRandom-effects modelPrevalence of tramadol useMisuse of tramadolPublic health consequencesReporting ItemsHealth challengesPrescription analgesicsGeneral populationHealth consequencesHeterogeneous reportingFemale university studentsTramadol-related deathsMeta-analysisTramadol useSubgroups of malesNon-prescribed usePooled percentage